Mode
Text Size
Log in / Sign up
N/A N=70 Randomized Treatment

Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease · Non-alcoholic Steatohepatitis

Enrolled (actual)
70
Serious AEs
0.0%
Results posted
May 2022
Primary outcome: Primary: Percent Change in Hepatic Steatosis as Measured by Controlled Attenuation Parameter (CAP) Score — -13.0; 8.7 percent change

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Usual Care then FitBit (Other); FitBit then Usual Care (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Michigan
Primary completion
Feb 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Percent Change in Hepatic Steatosis as Measured by Controlled Attenuation Parameter (CAP) Score
-13.0; 8.7
SECONDARY
Percent Change in Body Weight
NA
SECONDARY
Change in Physical Activity as Measured by International Physical Activity Questionnaire (IPAQ)
32.5; 42.5; 45; 30

Summary

This study will look at physical activity and nutrition in patients with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH). The researchers will see if providing patients with NAFLD/NASH with specific physical activity and nutrition feedback as an addition to their usual clinical care helps them to lose weight and improve liver-related parameters.

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH)
  • Access to mobile phone/tablet/ or computer compatible with FitBit application and ability to use said device and application
  • Ability to participate in physical activity

Exclusion Criteria

  • Any other form of liver disease( Alcohol related liver disease; viral hepatitis, autoimmune liver disease, hereditary forms of liver disease, etc.)
  • History of decompensated cirrhosis
  • Plans for invasive procedures or other regimented lifestyle programs for weight reduction
  • Cardiovascular event in the previous 3 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03839082). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search